<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font3" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font6" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font7" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font8" size="8" family="AkzidenzGroteskBE,BoldItalic" color="#000000"/>
	<fontspec id="font9" size="6" family="AkzidenzGroteskBE" color="#000000"/>
<text top="42" left="57" width="187" height="7" font="font0" id="p1_t1" reading_order_no="1" segment_no="0" tag_type="title">Breast Cancer Research Vol 7 No 6    Metsola et al.<b>Breast Cancer Research</b></text>
<text top="735" left="18" width="19" height="8" font="font3" id="p1_t2" reading_order_no="0" segment_no="12" tag_type="text">R990</text>
<text top="85" left="57" width="240" height="9" font="font4" id="p1_t3" reading_order_no="2" segment_no="1" tag_type="text">rized as those who had never been exposed to either passive<i>et al.</i></text>
<text top="97" left="57" width="240" height="9" font="font4" id="p1_t4" reading_order_no="3" segment_no="1" tag_type="text">or active smoking, and as those exposed to passive smoking</text>
<text top="109" left="57" width="240" height="9" font="font4" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">only. Ever smokers were further categorized according to the</text>
<text top="120" left="57" width="240" height="9" font="font4" id="p1_t6" reading_order_no="5" segment_no="1" tag_type="text">approximate median smoking years (15 years), daily consump-</text>
<text top="132" left="57" width="240" height="9" font="font4" id="p1_t7" reading_order_no="6" segment_no="1" tag_type="text">tion (10 cigarettes) and pack-years of smoking (5 pack-years)</text>
<text top="144" left="57" width="240" height="9" font="font4" id="p1_t8" reading_order_no="7" segment_no="1" tag_type="text">in the control population. Pack-years of cigarettes were calcu-</text>
<text top="156" left="57" width="240" height="9" font="font4" id="p1_t9" reading_order_no="8" segment_no="1" tag_type="text">lated as the number of packs (20 cigarettes/pack) smoked per</text>
<text top="167" left="57" width="136" height="9" font="font4" id="p1_t10" reading_order_no="9" segment_no="1" tag_type="text">day multiplied by years of smoking.</text>
<text top="191" left="57" width="240" height="9" font="font4" id="p1_t11" reading_order_no="10" segment_no="5" tag_type="text">Based on the prior knowledge of the functional significance or</text>
<text top="203" left="57" width="241" height="9" font="font4" id="p1_t12" reading_order_no="11" segment_no="5" tag_type="text">epidemiological evidence, the XRCC1-280 Arg/Arg and</text>
<text top="214" left="57" width="241" height="9" font="font5" id="p1_t13" reading_order_no="12" segment_no="5" tag_type="text">XRCC1-399 Arg/Arg genotypes were used as reference cat-</text>
<text top="226" left="57" width="240" height="9" font="font4" id="p1_t14" reading_order_no="13" segment_no="5" tag_type="text">egories for all separate analyses. As the frequency of the</text>
<text top="238" left="57" width="240" height="9" font="font5" id="p1_t15" reading_order_no="14" segment_no="5" tag_type="text">XRCC1-280 His variant allele was low, the ORs were calcu-<i>XRCC1-280 Arg/Arg </i></text>
<text top="250" left="57" width="240" height="9" font="font4" id="p1_t16" reading_order_no="15" segment_no="5" tag_type="text">lated for the combined XRCC1-280 His allele containing gen-</text>
<text top="261" left="57" width="240" height="9" font="font4" id="p1_t17" reading_order_no="16" segment_no="5" tag_type="text">otypes in all analyses. Similarly, in the stratified analyses, the<i>XRCC1-399 Arg/Arg </i></text>
<text top="273" left="57" width="240" height="9" font="font5" id="p1_t18" reading_order_no="17" segment_no="5" tag_type="text">XRCC1-399 Gln allele containing genotypes were combined</text>
<text top="285" left="57" width="240" height="9" font="font4" id="p1_t19" reading_order_no="18" segment_no="5" tag_type="text">to increase statistical power. In contrast, a recessive model</text>
<text top="297" left="57" width="240" height="9" font="font4" id="p1_t20" reading_order_no="19" segment_no="5" tag_type="text">was used for the XPD Lys751Gln polymorphism based on the<i>XRCC1-280 His </i></text>
<text top="308" left="57" width="240" height="9" font="font4" id="p1_t21" reading_order_no="20" segment_no="5" tag_type="text">observed genotype distributions and some earlier publications</text>
<text top="320" left="57" width="240" height="9" font="font4" id="p1_t22" reading_order_no="21" segment_no="5" tag_type="text">[42,51]. Therefore, the heterozygous XPD-751 Lys/Gln geno-</text>
<text top="332" left="57" width="240" height="9" font="font4" id="p1_t23" reading_order_no="22" segment_no="5" tag_type="text">type was combined with the wild-type Lys/Lys genotype to<i>XRCC1-280 His </i></text>
<text top="344" left="57" width="240" height="9" font="font4" id="p1_t24" reading_order_no="23" segment_no="5" tag_type="text">serve as a reference category. Possible gene environment</text>
<text top="355" left="57" width="240" height="9" font="font4" id="p1_t25" reading_order_no="24" segment_no="5" tag_type="text">interactions were assessed using stratified analyses and inter-</text>
<text top="367" left="57" width="241" height="9" font="font4" id="p1_t26" reading_order_no="25" segment_no="5" tag_type="text">action terms. Variables of interest were smoking and use of<i>XRCC1-399 Gln </i></text>
<text top="379" left="57" width="240" height="9" font="font4" id="p1_t27" reading_order_no="26" segment_no="5" tag_type="text">alcohol. Tests for interactions were assessed by the likelihood</text>
<text top="391" left="57" width="240" height="9" font="font4" id="p1_t28" reading_order_no="27" segment_no="5" tag_type="text">ratio test to compare goodness of fit of the model with the</text>
<text top="402" left="57" width="240" height="9" font="font4" id="p1_t29" reading_order_no="28" segment_no="5" tag_type="text">interaction term, to the reduced model including the main</text>
<text top="414" left="57" width="240" height="9" font="font4" id="p1_t30" reading_order_no="29" segment_no="5" tag_type="text">effect variable (genotype) and the main adjusting variables. All<i>XPD Lys751Gln </i></text>
<text top="426" left="57" width="241" height="9" font="font4" id="p1_t31" reading_order_no="30" segment_no="5" tag_type="text">reported p -values are two-sided. No attempt was made to</text>
<text top="438" left="57" width="124" height="9" font="font4" id="p1_t32" reading_order_no="31" segment_no="5" tag_type="text">adjust for multiple comparisons.</text>
<text top="461" left="57" width="39" height="10" font="font6" id="p1_t33" reading_order_no="32" segment_no="8" tag_type="title">Results<a href="">[42,51]. Ther</a>efore, the heterozygous </text>
<text top="473" left="57" width="240" height="9" font="font4" id="p1_t34" reading_order_no="33" segment_no="9" tag_type="text">Characteristics of the study population are shown in Table 1.<i>XPD-751 Lys/Gln </i></text>
<text top="485" left="57" width="240" height="9" font="font4" id="p1_t35" reading_order_no="34" segment_no="9" tag_type="text">Parity was associated with decreased risk of breast cancer</text>
<text top="496" left="57" width="240" height="9" font="font4" id="p1_t36" reading_order_no="35" segment_no="9" tag_type="text">while higher waist-to-hip ratio, first degree family history of</text>
<text top="508" left="57" width="240" height="9" font="font4" id="p1_t37" reading_order_no="36" segment_no="9" tag_type="text">breast cancer and history of benign breast disease were asso-<i>Lys/Lys </i></text>
<text top="520" left="57" width="240" height="9" font="font4" id="p1_t38" reading_order_no="37" segment_no="9" tag_type="text">ciated with increased risk. No significant associations were</text>
<text top="532" left="57" width="240" height="9" font="font4" id="p1_t39" reading_order_no="38" segment_no="9" tag_type="text">seen between breast cancer risk and smoking habits. Neither</text>
<text top="543" left="57" width="240" height="9" font="font4" id="p1_t40" reading_order_no="39" segment_no="9" tag_type="text">were any statistically significant differences seen in the mean</text>
<text top="555" left="57" width="240" height="9" font="font4" id="p1_t41" reading_order_no="40" segment_no="9" tag_type="text">number of cigarettes smoked per day (mean 11.2, SD 9.2, and</text>
<text top="567" left="57" width="240" height="9" font="font4" id="p1_t42" reading_order_no="41" segment_no="9" tag_type="text">mean 9.5, SD 6.7, for cases and controls, respectively, p =</text>
<text top="579" left="57" width="240" height="9" font="font4" id="p1_t43" reading_order_no="42" segment_no="9" tag_type="text">0.10), or in smoking years (16.1, SD 10.8, and 14.5, SD 10.8,</text>
<text top="590" left="57" width="182" height="9" font="font4" id="p1_t44" reading_order_no="43" segment_no="9" tag_type="text">for cases and controls, respectively, p = 0.25).</text>
<text top="614" left="57" width="240" height="9" font="font4" id="p1_t45" reading_order_no="44" segment_no="10" tag_type="text">The frequencies of the XRCC1-280 His , XRCC1-399 Gln ,</text>
<text top="626" left="57" width="240" height="9" font="font4" id="p1_t46" reading_order_no="45" segment_no="10" tag_type="text">and XPD-751 Gln variant alleles in controls were 0.08, 0.27,</text>
<text top="637" left="57" width="240" height="9" font="font4" id="p1_t47" reading_order_no="46" segment_no="10" tag_type="text">and 0.43, respectively. All the genotype distributions in the<i>p</i></text>
<text top="649" left="57" width="240" height="9" font="font4" id="p1_t48" reading_order_no="47" segment_no="10" tag_type="text">control population conformed to Hardy-Weinberg equilibrium</text>
<text top="661" left="57" width="240" height="9" font="font4" id="p1_t49" reading_order_no="48" segment_no="10" tag_type="text">( p = 0.993, p = 0.657, and p = 0.876 for XRCC1-280 ,</text>
<text top="673" left="57" width="240" height="9" font="font5" id="p1_t50" reading_order_no="49" segment_no="10" tag_type="text">XRCC1-399 , and XPD-751 locuses, respectively). No statis-<b>Results</b></text>
<text top="684" left="57" width="240" height="9" font="font4" id="p1_t51" reading_order_no="50" segment_no="10" tag_type="text">tically significant differences were seen in the frequency of<a href=""> Table 1.</a></text>
<text top="696" left="57" width="240" height="9" font="font4" id="p1_t52" reading_order_no="51" segment_no="10" tag_type="text">these genotypes between cases and controls (Table 2). Nei-</text>
<text top="708" left="57" width="240" height="9" font="font4" id="p1_t53" reading_order_no="52" segment_no="10" tag_type="text">ther was any significant difference seen for the polymorphisms</text>
<text top="720" left="57" width="240" height="9" font="font4" id="p1_t54" reading_order_no="53" segment_no="10" tag_type="text">when stratified by menopausal status or age (data not shown).</text>
<text top="436" left="315" width="240" height="9" font="font4" id="p1_t55" reading_order_no="115" segment_no="7" tag_type="text">When subjects were studied by the stage of the disease at the</text>
<text top="448" left="315" width="240" height="9" font="font4" id="p1_t56" reading_order_no="116" segment_no="7" tag_type="text">time of diagnosis, a significant increase for advanced stage (III</text>
<text top="459" left="315" width="241" height="9" font="font4" id="p1_t57" reading_order_no="117" segment_no="7" tag_type="text">or IV) breast cancer was seen for women with the XRCC1-</text>
<text top="471" left="315" width="241" height="9" font="font5" id="p1_t58" reading_order_no="118" segment_no="7" tag_type="text">399 Gln/Gln genotype (OR 2.86, 95% CI 1.05–7.81) com-</text>
<text top="483" left="315" width="241" height="9" font="font4" id="p1_t59" reading_order_no="119" segment_no="7" tag_type="text">pared to those with the Arg/Arg genotype. No increase in risk</text>
<text top="495" left="315" width="240" height="9" font="font4" id="p1_t60" reading_order_no="120" segment_no="7" tag_type="text">was seen for lower stage (I or II) breast cancer (OR 1.33, 95%<i>p </i></text>
<text top="506" left="315" width="240" height="9" font="font4" id="p1_t61" reading_order_no="121" segment_no="7" tag_type="text">CI 0.79–2.26). A similar tendency of increased risk for</text>
<text top="518" left="315" width="240" height="9" font="font4" id="p1_t62" reading_order_no="122" segment_no="7" tag_type="text">advanced stage cancer was seen for subjects with the</text>
<text top="530" left="315" width="241" height="9" font="font5" id="p1_t63" reading_order_no="123" segment_no="7" tag_type="text">XRCC1-280 Arg/His or His/His genotype (OR 1.99, 95% CI</text>
<text top="542" left="315" width="241" height="9" font="font4" id="p1_t64" reading_order_no="124" segment_no="7" tag_type="text">0.90–4.42) compared to subjects with the Arg/Arg genotype.<i>p </i></text>
<text top="553" left="315" width="240" height="9" font="font4" id="p1_t65" reading_order_no="125" segment_no="7" tag_type="text">Similarly, women with the XRCC1-399 Gln/Gln genotype pre-</text>
<text top="565" left="315" width="241" height="9" font="font4" id="p1_t66" reading_order_no="126" segment_no="7" tag_type="text">sented with a significantly increased risk for grade II and grade</text>
<text top="577" left="315" width="240" height="9" font="font4" id="p1_t67" reading_order_no="127" segment_no="7" tag_type="text">III tumours (OR 1.80, 95% CI 1.06–3.07) when compared to<i>XRCC1-280 His</i></text>
<text top="589" left="315" width="241" height="9" font="font4" id="p1_t68" reading_order_no="128" segment_no="7" tag_type="text">those with the Arg/Arg genotype, while no increase was seen</text>
<text top="600" left="315" width="240" height="9" font="font4" id="p1_t69" reading_order_no="129" segment_no="7" tag_type="text">for grade I tumours (OR 1.10, 95% CI 0.75–1.62). Moreover,<i>XRCC1-399 Gln</i></text>
<text top="612" left="315" width="240" height="9" font="font4" id="p1_t70" reading_order_no="130" segment_no="7" tag_type="text">women who carried the XRCC1-399 Gln/Gln genotype and</text>
<text top="624" left="315" width="240" height="9" font="font4" id="p1_t71" reading_order_no="131" segment_no="7" tag_type="text">were diagnosed with early stage (I or II) breast cancer had</text>
<text top="636" left="315" width="240" height="9" font="font4" id="p1_t72" reading_order_no="132" segment_no="7" tag_type="text">tumours of higher grade (II or III) marginally ( p = 0.065, one-<i>XPD-751 Gln </i></text>
<text top="647" left="315" width="241" height="9" font="font4" id="p1_t73" reading_order_no="133" segment_no="7" tag_type="text">sided) more often than those with the Arg/Arg genotype,</text>
<text top="659" left="315" width="216" height="9" font="font4" id="p1_t74" reading_order_no="134" segment_no="7" tag_type="text">86.1% (31/36) versus 72.5 % (137/189), respectively.</text>
<text top="683" left="315" width="241" height="9" font="font4" id="p1_t75" reading_order_no="135" segment_no="11" tag_type="text">When the association between XRCC1-399 genotypes and</text>
<text top="694" left="315" width="241" height="9" font="font4" id="p1_t76" reading_order_no="136" segment_no="11" tag_type="text">breast cancer risk was studied according to smoking habits,</text>
<text top="706" left="315" width="240" height="9" font="font4" id="p1_t77" reading_order_no="137" segment_no="11" tag_type="text">increased breast cancer risk with dose-response was seen<i>p </i></text>
<text top="718" left="315" width="240" height="9" font="font4" id="p1_t78" reading_order_no="138" segment_no="11" tag_type="text">among women who had ever smoked actively and carried</text>
<text top="730" left="315" width="241" height="9" font="font4" id="p1_t79" reading_order_no="139" segment_no="11" tag_type="text">either one (OR 2.14, 95% CI 1.15–3.97) or two (OR 3.27,<i>p </i></text>
<text top="85" left="315" width="28" height="7" font="font7" id="p1_t80" reading_order_no="54" segment_no="2" tag_type="title">Table 2</text>
<text top="104" left="315" width="225" height="7" font="font7" id="p1_t81" reading_order_no="55" segment_no="3" tag_type="text">Association between XRCC1 and XPD polymorphisms and<i>p </i></text>
<text top="113" left="315" width="68" height="7" font="font7" id="p1_t82" reading_order_no="56" segment_no="3" tag_type="text">breast cancer risk</text>
<text top="132" left="317" width="34" height="7" font="font1" id="p1_t83" reading_order_no="57" segment_no="4" tag_type="table">Genotype<i>XRCC1-280</i></text>
<text top="132" left="398" width="86" height="7" font="font1" id="p1_t84" reading_order_no="58" segment_no="4" tag_type="table">Cases (%) Controls (%)</text>
<text top="132" left="498" width="48" height="7" font="font1" id="p1_t85" reading_order_no="59" segment_no="4" tag_type="table">OR (95% CI) a<i>XRCC1-399</i></text>
<text top="148" left="317" width="43" height="7" font="font2" id="p1_t86" reading_order_no="60" segment_no="4" tag_type="table">XRCC1-280</text>
<text top="164" left="327" width="27" height="7" font="font2" id="p1_t87" reading_order_no="61" segment_no="4" tag_type="table">Arg/Arg<i>XPD-751 </i></text>
<text top="164" left="398" width="37" height="7" font="font1" id="p1_t88" reading_order_no="62" segment_no="4" tag_type="table">399 (83.1)</text>
<text top="164" left="444" width="37" height="7" font="font1" id="p1_t89" reading_order_no="63" segment_no="4" tag_type="table">406 (84.8)</text>
<text top="164" left="516" width="11" height="7" font="font1" id="p1_t90" reading_order_no="64" segment_no="4" tag_type="table">1.0<a href=""> 2). Nei-</a></text>
<text top="179" left="327" width="26" height="7" font="font2" id="p1_t91" reading_order_no="65" segment_no="4" tag_type="table">Arg/His</text>
<text top="179" left="400" width="32" height="7" font="font1" id="p1_t92" reading_order_no="66" segment_no="4" tag_type="table">78 (16.3)</text>
<text top="179" left="447" width="32" height="7" font="font1" id="p1_t93" reading_order_no="67" segment_no="4" tag_type="table">70 (14.6)</text>
<text top="195" left="327" width="26" height="7" font="font2" id="p1_t94" reading_order_no="68" segment_no="4" tag_type="table">His/His</text>
<text top="195" left="405" width="23" height="7" font="font1" id="p1_t95" reading_order_no="69" segment_no="4" tag_type="table">3 (0.6)</text>
<text top="195" left="451" width="23" height="7" font="font1" id="p1_t96" reading_order_no="70" segment_no="4" tag_type="table">3 (0.6)<i>XRCC1-</i></text>
<text top="195" left="491" width="62" height="7" font="font1" id="p1_t97" reading_order_no="71" segment_no="4" tag_type="table">1.15 (0.80–1.66) b<i>399 Gln/Gln </i></text>
<text top="210" left="317" width="43" height="7" font="font2" id="p1_t98" reading_order_no="72" segment_no="4" tag_type="table">XRCC1-399</text>
<text top="226" left="327" width="27" height="7" font="font2" id="p1_t99" reading_order_no="73" segment_no="4" tag_type="table">Arg/Arg</text>
<text top="226" left="398" width="37" height="7" font="font1" id="p1_t100" reading_order_no="74" segment_no="4" tag_type="table">237 (49.5)<i>Arg/Arg </i></text>
<text top="226" left="444" width="37" height="7" font="font1" id="p1_t101" reading_order_no="75" segment_no="4" tag_type="table">256 (53.6)</text>
<text top="226" left="516" width="11" height="7" font="font1" id="p1_t102" reading_order_no="76" segment_no="4" tag_type="table">1.0</text>
<text top="241" left="327" width="27" height="7" font="font2" id="p1_t103" reading_order_no="77" segment_no="4" tag_type="table">Arg/Gln</text>
<text top="241" left="398" width="37" height="7" font="font1" id="p1_t104" reading_order_no="78" segment_no="4" tag_type="table">196 (40.9)</text>
<text top="241" left="444" width="37" height="7" font="font1" id="p1_t105" reading_order_no="79" segment_no="4" tag_type="table">185 (38.7)<i>XRCC1-280 Arg/His </i></text>
<text top="241" left="492" width="59" height="7" font="font1" id="p1_t106" reading_order_no="80" segment_no="4" tag_type="table">1.24 (0.93–1.65)</text>
<text top="257" left="327" width="27" height="7" font="font2" id="p1_t107" reading_order_no="81" segment_no="4" tag_type="table">Gln/Gln<i>His/His </i></text>
<text top="257" left="403" width="28" height="7" font="font1" id="p1_t108" reading_order_no="82" segment_no="4" tag_type="table">46 (9.6)</text>
<text top="257" left="449" width="28" height="7" font="font1" id="p1_t109" reading_order_no="83" segment_no="4" tag_type="table">37 (7.7)</text>
<text top="257" left="491" width="62" height="7" font="font1" id="p1_t110" reading_order_no="84" segment_no="4" tag_type="table">1.39 (0.84–2.29) c<i>Arg/Arg </i></text>
<text top="272" left="327" width="108" height="7" font="font2" id="p1_t111" reading_order_no="85" segment_no="4" tag_type="table">Arg/Gln + Gln/Gln 242 (50.5)</text>
<text top="272" left="444" width="37" height="7" font="font1" id="p1_t112" reading_order_no="86" segment_no="4" tag_type="table">222 (46.4)</text>
<text top="272" left="492" width="59" height="7" font="font1" id="p1_t113" reading_order_no="87" segment_no="4" tag_type="table">1.26 (0.96–1.66)<i>XRCC1-399 Gln/Gln </i></text>
<text top="288" left="317" width="32" height="7" font="font2" id="p1_t114" reading_order_no="88" segment_no="4" tag_type="table">XPD-751</text>
<text top="303" left="327" width="26" height="7" font="font2" id="p1_t115" reading_order_no="89" segment_no="4" tag_type="table">Lys/Lys</text>
<text top="303" left="398" width="37" height="7" font="font1" id="p1_t116" reading_order_no="90" segment_no="4" tag_type="table">147 (30.6)</text>
<text top="303" left="444" width="37" height="7" font="font1" id="p1_t117" reading_order_no="91" segment_no="4" tag_type="table">155 (32.3)</text>
<text top="303" left="516" width="11" height="7" font="font1" id="p1_t118" reading_order_no="92" segment_no="4" tag_type="table">1.0<i>Arg/Arg </i></text>
<text top="319" left="327" width="27" height="7" font="font2" id="p1_t119" reading_order_no="93" segment_no="4" tag_type="table">Lys/Gln</text>
<text top="319" left="398" width="37" height="7" font="font1" id="p1_t120" reading_order_no="94" segment_no="4" tag_type="table">238 (49.5)</text>
<text top="319" left="444" width="37" height="7" font="font1" id="p1_t121" reading_order_no="95" segment_no="4" tag_type="table">237 (49.4)</text>
<text top="319" left="492" width="59" height="7" font="font1" id="p1_t122" reading_order_no="96" segment_no="4" tag_type="table">1.03 (0.76–1.40)<i>XRCC1-399 Gln/Gln </i></text>
<text top="334" left="327" width="27" height="7" font="font2" id="p1_t123" reading_order_no="97" segment_no="4" tag_type="table">Gln/Gln</text>
<text top="334" left="400" width="32" height="7" font="font1" id="p1_t124" reading_order_no="98" segment_no="4" tag_type="table">96 (20.0)</text>
<text top="334" left="447" width="32" height="7" font="font1" id="p1_t125" reading_order_no="99" segment_no="4" tag_type="table">88 (18.3)</text>
<text top="334" left="492" width="59" height="7" font="font1" id="p1_t126" reading_order_no="100" segment_no="4" tag_type="table">1.10 (0.74–1.63)<i>p </i></text>
<text top="350" left="327" width="58" height="7" font="font2" id="p1_t127" reading_order_no="101" segment_no="4" tag_type="table">Lys/Lys+Lys/Gln</text>
<text top="350" left="398" width="37" height="7" font="font1" id="p1_t128" reading_order_no="102" segment_no="4" tag_type="table">385 (80.0)</text>
<text top="350" left="444" width="37" height="7" font="font1" id="p1_t129" reading_order_no="103" segment_no="4" tag_type="table">325 (81.7)<i>Arg/Arg </i></text>
<text top="350" left="516" width="11" height="7" font="font1" id="p1_t130" reading_order_no="104" segment_no="4" tag_type="table">1.0</text>
<text top="365" left="327" width="27" height="7" font="font2" id="p1_t131" reading_order_no="105" segment_no="4" tag_type="table">Gln/Gln</text>
<text top="365" left="400" width="32" height="7" font="font1" id="p1_t132" reading_order_no="106" segment_no="4" tag_type="table">96 (20.0)</text>
<text top="365" left="447" width="32" height="7" font="font1" id="p1_t133" reading_order_no="107" segment_no="4" tag_type="table">88 (18.3)<i>XRCC1-399 </i></text>
<text top="365" left="492" width="59" height="7" font="font1" id="p1_t134" reading_order_no="108" segment_no="4" tag_type="table">1.08 (0.77–1.53)</text>
<text top="381" left="317" width="231" height="8" font="font1" id="p1_t135" reading_order_no="109" segment_no="6" tag_type="text">a Odds ratios (ORs) and confidence intervals (CIs) adjusted for age,</text>
<text top="390" left="317" width="204" height="7" font="font1" id="p1_t136" reading_order_no="110" segment_no="6" tag_type="text">age at menarche, age at first full term pregnancy, number of</text>
<text top="398" left="317" width="220" height="7" font="font1" id="p1_t137" reading_order_no="111" segment_no="6" tag_type="text">pregnancies, history of benign breast disease, first degree family</text>
<text top="406" left="317" width="213" height="7" font="font1" id="p1_t138" reading_order_no="112" segment_no="6" tag_type="text">history of breast cancer, weist-to-hip ratio, smoking and use of</text>
<text top="413" left="317" width="226" height="8" font="font1" id="p1_t139" reading_order_no="113" segment_no="6" tag_type="text">alcohol. b OR for Arg/His and His/His genotypes combined. c p for<b>Table 2</b></text>
<text top="422" left="317" width="50" height="7" font="font1" id="p1_t140" reading_order_no="114" segment_no="6" tag_type="text">trend = 0.105.<b>Association between </b></text>
</page>
</pdf2xml>
